Rao, Ravi D <br/><br/>
Phase II trial of carmustine, cisplatin, and oral etoposide chemotherapy before radiotherapy for grade 3 astrocytoma (anaplastic astrocytoma): results of North Central Cancer Treatment Group trial 98-72-51.  [electronic resource] 

 -  International journal of radiation oncology, biology, physics  Feb 2005 
 - 380-6 p.  digital 
<br/><br/> Publication Type: Clinical Trial; Clinical Trial, Phase II; Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>0360-3016 
<br/><br/><label>Standard No.: </label>10.1016/j.ijrobp.2004.06.258  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Administration, Oral<br/>Adult<br/>Aged<br/>Antineoplastic Combined Chemotherapy Protocols--adverse effects<br/>Astrocytoma--drug therapy<br/>Brain Neoplasms--drug therapy<br/>Carmustine--administration & dosage<br/>Cisplatin--administration & dosage<br/>Combined Modality Therapy<br/>Drug Administration Schedule<br/>Etoposide--administration & dosage<br/>Female<br/>Humans<br/>Male<br/>Middle Aged<br/>Radiotherapy Dosage<br/>Survival Rate